Mar 5 |
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
|
Mar 5 |
Earnings Scheduled For March 5, 2024
|
Mar 4 |
Tracon Q4 2023 Earnings Preview
|
Feb 28 |
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
|
Dec 20 |
TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
|
Nov 21 |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
|
Nov 20 |
TRACON announces license of product development platform for $3M upfront payment
|
Nov 20 |
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment
|
Nov 12 |
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call Transcript
|
Nov 10 |
Dow Gains Over 100 Points; Wynn Resorts Earnings Top Views
|